FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing.
Silver Springs, MD: US Food and Drug Administration: June 25, 2021.
Incomplete reprocessing of reusable flexible endoscopes can result in nosocomial infection. This announcement highlights recent guidance to improve the safe reuse of bronchoscopes with a focus on scope design, sterile processing, and infection control program management.